Influence of retinal coagulation status on retinal oxidative metabolites and VEGF level in 208 patients suffering from proliferative diabetic retinopathy;Einfluss des retinalen koagulationsstatus auf oxidative metabolite und VEGF bei 208 patienten mit proliferativer diabetischer retinopathie

Klinische Monatsblatter fur Augenheilkunde

Volumn 218, Issue 2, 2001, Pages 89-94

  Augustin, A J ^a   Keller, A ^a   Koch, F ^b   Jurklies, B ^c   Dick, B ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Diabetes mellitus; Oxidative metabolites; Retinopathy; VEGF

Indexed keywords

LIPID PEROXIDE; MALONALDEHYDE; VASCULOTROPIN;

ARTICLE; CRYOCOAGULATION; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; OXIDATION; VITRECTOMY; VITREOUS BODY;

EID: 0035089273     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12251     Document Type: Article

References (32)

1. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
2. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
3. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
4. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor using soluble VEGF-receptor chimeric proteins
5. Influence of retinal coagulation area and blood glucose control on oxidative metabolites and VEGF in ocular tissues of diabetic patients
6. Role of oxidative stress in development of complications in diabetes
7. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes
8. Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications
9. Vitamin E reduction of protein glycosylation in diabetes
10. Photocoagulation treatment of proliferative diabetic retinopathy: The second report from the Diabetic Retinopathy Study findings
11. Anti-Oxidants may reduce retinopathy risk for diabetes
12. The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells
13. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells
14. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes
15. New approaches to the pathogenesis and treatment of diabetic microangiopathy
16. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
17. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo
18. Detection of vascular endothelial growth factor messenger RNA and vascular endothelilal growth factor-like activity in proliferative diabetic retinopathy
19. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease
20. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
21. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels
22. Assay for lipid peroxides in animal tissues by thiobarbituric acid
23. Quantitation of retinal ablation in proliferative diabetic retinopathy
24. Vitamin and Diabetes Fat
25. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis
26. A simplified method for the quantitative assay of small amounts of protein in biologic material
27. Determination of plasma lipoperoxides by high-performance liquid chromatography
28. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells
29. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate
30. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
31. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus
32. Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes